These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34928578)

  • 1. Advances in Biosensor Technologies for Acute Kidney Injury.
    Derin E; Inci F
    ACS Sens; 2022 Feb; 7(2):358-385. PubMed ID: 34928578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refreshable Nanobiosensor Based on Organosilica Encapsulation of Biorecognition Elements.
    Gupta R; Luan J; Chakrabartty S; Scheller EL; Morrissey J; Singamaneni S
    ACS Appl Mater Interfaces; 2020 Feb; 12(5):5420-5428. PubMed ID: 31913006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Label-free plasmonic biosensors for point-of-care diagnostics: a review.
    Soler M; Huertas CS; Lechuga LM
    Expert Rev Mol Diagn; 2019 Jan; 19(1):71-81. PubMed ID: 30513011
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances in point-of-care platforms for traumatic brain injury: recent developments in diagnostics.
    Habli Z; Kobeissy F; Khraiche ML
    Rev Neurosci; 2022 Apr; 33(3):327-345. PubMed ID: 35170265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors.
    Alawieh H; Chemaly TE; Alam S; Khraiche M
    Sensors (Basel); 2019 Nov; 19(22):. PubMed ID: 31744130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmonic-based platforms for diagnosis of infectious diseases at the point-of-care.
    Li Z; Leustean L; Inci F; Zheng M; Demirci U; Wang S
    Biotechnol Adv; 2019 Dec; 37(8):107440. PubMed ID: 31476421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guide to Selecting a Biorecognition Element for Biosensors.
    Morales MA; Halpern JM
    Bioconjug Chem; 2018 Oct; 29(10):3231-3239. PubMed ID: 30216055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in nanoplasmonic biosensors for clinical applications.
    Mauriz E; Dey P; Lechuga LM
    Analyst; 2019 Dec; 144(24):7105-7129. PubMed ID: 31663527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Biorecognition Elements against Pathogens in the Design of State-of-the-Art Diagnostics.
    Sande MG; Rodrigues JL; Ferreira D; Silva CJ; Rodrigues LR
    Biosensors (Basel); 2021 Oct; 11(11):. PubMed ID: 34821636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrochemical cardiovascular platforms: Current state of the art and beyond.
    Szunerits S; Mishyn V; Grabowska I; Boukherroub R
    Biosens Bioelectron; 2019 Apr; 131():287-298. PubMed ID: 30851492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point-of-care cancer diagnostic devices: From academic research to clinical translation.
    Syedmoradi L; Norton ML; Omidfar K
    Talanta; 2021 Apr; 225():122002. PubMed ID: 33592810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances on Electrochemical Biosensing Strategies toward Universal Point-of-Care Systems.
    Dai Y; Liu CC
    Angew Chem Int Ed Engl; 2019 Sep; 58(36):12355-12368. PubMed ID: 30990933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the surface ligand on the performance of electrochemical SARS-CoV-2 antigen biosensors.
    Szunerits S; Pagneux Q; Swaidan A; Mishyn V; Roussel A; Cambillau C; Devos D; Engelmann I; Alidjinou EK; Happy H; Boukherroub R
    Anal Bioanal Chem; 2022 Jan; 414(1):103-113. PubMed ID: 33616686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Nucleic Acids for Pathogenic Bacteria Detection.
    Chang D; Zakaria S; Esmaeili Samani S; Chang Y; Filipe CDM; Soleymani L; Brennan JD; Liu M; Li Y
    Acc Chem Res; 2021 Sep; 54(18):3540-3549. PubMed ID: 34478272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in diagnosis of Helicobacter pylori through biosensors: Point of care devices.
    Saxena K; Chauhan N; Jain U
    Anal Biochem; 2021 Oct; 630():114325. PubMed ID: 34352253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Electrochemical Biosensing Trends for Rapid Diagnosis of COVID-19 Biomarkers as Point-of-Care Platforms: A Critical Review.
    Madhurantakam S; Muthukumar S; Prasad S
    ACS Omega; 2022 Apr; 7(15):12467-12473. PubMed ID: 35474766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosensor Technologies in Medicine: from Detection of Biochemical Markers to Research into Molecular Targets (Review).
    Andryukov BG; Lyapun IN; Matosova EV; Somova LM
    Sovrem Tekhnologii Med; 2021; 12(6):70-83. PubMed ID: 34796021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances of Point-of-Care Devices Integrated with Molecularly Imprinted Polymers-Based Biosensors: From Biomolecule Sensing Design to Intraoral Fluid Testing.
    Park R; Jeon S; Jeong J; Park SY; Han DW; Hong SW
    Biosensors (Basel); 2022 Feb; 12(3):. PubMed ID: 35323406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference.
    McCullough PA; Shaw AD; Haase M; Bouchard J; Waikar SS; Siew ED; Murray PT; Mehta RL; Ronco C
    Contrib Nephrol; 2013; 182():13-29. PubMed ID: 23689653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamer-Based Point-of-Care Devices: Emerging Technologies and Integration of Computational Methods.
    Aslan Y; Atabay M; Chowdhury HK; Göktürk I; Saylan Y; Inci F
    Biosensors (Basel); 2023 May; 13(5):. PubMed ID: 37232930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.